首页 | 本学科首页   官方微博 | 高级检索  
检索        

miRNA-155/PU.1信号通路阻滞对大鼠骨髓来源树突状细胞成熟及移植免疫的影响
引用本文:徐兴伟,丁博文,朱传荣,郑鹏,冯涛,嵇武.miRNA-155/PU.1信号通路阻滞对大鼠骨髓来源树突状细胞成熟及移植免疫的影响[J].普外基础与临床杂志,2014(2):168-172.
作者姓名:徐兴伟  丁博文  朱传荣  郑鹏  冯涛  嵇武
作者单位:[1]南京大学医学院临床学院南京军区南京总医院普通外科研究所,江苏南京210002 [2]徐州市中医院普外科,江苏徐州221000 [3]淮安市第一人民医院普外科,江苏淮安223001
基金项目:IL-12p70 secretion levels in the supematant were tested by ELISA method. The allogeneic T lymphocyte proliferation was tested by mixed lymphocyte reaction. The transfected cells were intravenously injected into the recipient rat on day 7 before intestinal transplantation. The survival conditions as well as pathological changes were observed in each group recipients. Results OThe surface molecules CD80, CD86, and MHC-I] in the PU.1 silent group were (27. 0+5.6)%, (23.6 +4. 8) %, and (36.8 q-6.8) %, respectively; versus (74. 0 + 9.4) %, (76. 5 + 8.7) %, and (87.8 + 1 I. 3) % in the negative control group, respectively, which were significantly lower in former and showing an in creased trend (P〈0. 05). (~) Compared with the negative control group, IL-10 secretion level was significantly increased (P〈0.05), IL-12p70 secretion level significantly decreased (P 〈 0.05) in the PU.1 silent group. (~) The proliferation ofT lymphocytes in the PU.1 silent group was significantly lower than that in the negative control group (P〈0. 05). (~)When the transfected DCs were injected into the intestinal transplantation rats on day 7 before operation, the survival time was (14. 3 +3.3) d, (7. 8+ 1.5) d, and (8.0+2.5) d in the PU.1 silent group, negative control group, and control group, respectively, which in the PU. 1 silent group were significantly longer than that in the other two groups (P 〈 0.05), and the graft pathology showed that there were mild intestinal tissue damage, lymphocyte infiltration or villus edema in the PU. 1 silent group. Coneluslon miRNA-155/PU.1 signaling pathway blockade could reduce DCs maturation and induce receptor-specific immune tolerance, which are proved both in vivo and in vitro.
摘    要:目的探讨miRNA-155/PU-1信号通路阻滞对骨髓来源树突状细胞(DCs)成熟及其对应用于大鼠小肠移植中的免疫功能的影响。方法利用贴壁法培养诱导DCs,针对miRNA-155/PU-1信号通路中关键转录因子PU.1基因设计并合成3对PU.1siRNA(Pu.1沉默组、阴性对照组及对照组),用脂质体法转染细胞,并筛选一对高沉默效率PU.1siRNA。流式细胞术分析PU.1沉默组、阴性对照组及对照组细胞表面CD80、CD86及主要组织相容性复合体(MHC)-II的表达;ELISA法检测上清液中IL.10及IL.12p70的水平;混合淋巴细胞反应检测对同种异体T淋巴细胞的增殖作用;在大鼠小肠移植前7d经受体尾静脉等量注射3组细胞,移植后观察各组受体存活情况及移植物病理情况。结果①DCs表面分子CD80、CD86和MHC一1I表达率在PU.1沉默组分别为(27.0±5.6)%、(23.6+4.8)%及(36.8±6.8)%,阴性对照组分别为(74.0±9.4)%、(76.5±8.7)%及(87.8±11.3)%,PU.1沉默组均分别明显低于阴性对照组(尸〈0.05)。②PU.1沉默组IL.10水平较阴性对照组明显升高(尸〈0.05),IL-12p70则明显降低(尸〈0.05)。③PU.1沉默组DCs刺激同种异体T淋巴细胞增殖也较阴性对照组明显降低(尸〈0.05)。④将PU.1沉默组DCs术前注入受体行大鼠小肠移植后,受体平均存活时间为(14.3±3.3)d,明显长于阴性对照组的(7.8±1.5)d(尸〈0.05)和对照组的(8.0+2.5)d(P〈0.05),且术后5d时移植物病理显示移植肠组织轻度淋巴细胞浸润和绒毛水肿。结论体内外实验表明,miRNA-155/PU.1信号通路阻滞的DCs成熟度明显受到抑制,并能稳定发挥诱导受体特异性免疫耐受的作用。

关 键 词:树突状细胞  miRNA-155  PU  1  免疫耐受  小肠移植

Influences of miRNA-155/PU.1 Signaling Pathway Blockade on Rat Bone Marrow-Derived Dendritic Cell Maturationand Transplantation Immunity
Institution:XU Xing-w, DING Bo-wen, ZHU Chuan-rong, ZHENG Peng, FENG Tao, J1 Wu. 1. School of Medicine, Nanjing University, Research Institute of General Surgery, Jinling Hospital, Nanjing 210002, Jiangsu Province, China; 2. Department of General Surgery, Xuzhou Chinese Medicine Hospital, Xuzhou 221000, Jiangsu Province, China; 3. Department of General Surgery, Huaian First People's Hospital, Huaian 223001, Jiangsu Province, China
Abstract:
Keywords:Dendritic cell  miRNA-155/PU  1  Immune tolerance  Intestinal transplantation
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号